These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9514878)
1. Discovery of nonsteroidal androgens. Dalton JT; Mukherjee A; Zhu Z; Kirkovsky L; Miller DD Biochem Biophys Res Commun; 1998 Mar; 244(1):1-4. PubMed ID: 9514878 [TBL] [Abstract][Full Text] [Related]
2. Rainbow trout androgen receptor-alpha fails to distinguish between any of the natural androgens tested in transactivation assay, not just 11-ketotestosterone and testosterone. Takeo J; Yamashita S Gen Comp Endocrinol; 2000 Feb; 117(2):200-6. PubMed ID: 10642442 [TBL] [Abstract][Full Text] [Related]
3. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690 [TBL] [Abstract][Full Text] [Related]
4. Steroid-binding properties of the androgen receptor of rat seminal vesicle. Zakár T; Tóth M Endokrinologie; 1982 Nov; 80(3):257-65. PubMed ID: 7166157 [TBL] [Abstract][Full Text] [Related]
6. Stabilization of androgen receptor by nonandrogenic steroids. Nemoto T; Ohara-Nemoto Y; Sato M; Ota M Biochem Int; 1986 May; 12(5):701-5. PubMed ID: 3488063 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. Wang LG; Liu XM; Kreis W; Budman DR Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909 [TBL] [Abstract][Full Text] [Related]
8. Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands. Mukherjee A; Kirkovsky LI; Kimura Y; Marvel MM; Miller DD; Dalton JT Biochem Pharmacol; 1999 Oct; 58(8):1259-67. PubMed ID: 10487527 [TBL] [Abstract][Full Text] [Related]
9. Selective androgen receptor modulators: in pursuit of tissue-selective androgens. Omwancha J; Brown TR Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931 [TBL] [Abstract][Full Text] [Related]
10. Tissue-specific pharmacology of testosterone and 5 alpha-dihydrotestosterone analogues: characterization of a novel canine liver androgen-binding protein. Summerfield AE; Diaz Cruz PJ; Dolenga MP; Smith HE; Strader CD; Toney JH Mol Pharmacol; 1995 May; 47(5):1080-8. PubMed ID: 7746275 [TBL] [Abstract][Full Text] [Related]
11. Different binding of testosterone, 19-nortestosterone and their 5 alpha-reduced derivatives to the androgen receptor of the rat seminal vesicle: a step toward the understanding of the anabolic action of nortesterone. Tóth M; Zakár T Endokrinologie; 1982 Oct; 80(2):163-72. PubMed ID: 7160340 [TBL] [Abstract][Full Text] [Related]
12. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex. Marcelli M; Zoppi S; Wilson CM; Griffin JE; McPhaul MJ J Clin Invest; 1994 Oct; 94(4):1642-50. PubMed ID: 7929841 [TBL] [Abstract][Full Text] [Related]
14. Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor. He Y; Yin D; Perera M; Kirkovsky L; Stourman N; Li W; Dalton JT; Miller DD Eur J Med Chem; 2002 Aug; 37(8):619-34. PubMed ID: 12161060 [TBL] [Abstract][Full Text] [Related]
15. Stabilization of androgen receptor protein is induced by agonist, not by antagonists. Furutani T; Watanabe T; Tanimoto K; Hashimoto T; Koutoku H; Kudoh M; Shimizu Y; Kato S; Shikama H Biochem Biophys Res Commun; 2002 Jun; 294(4):779-84. PubMed ID: 12061774 [TBL] [Abstract][Full Text] [Related]
16. Enantioselective binding of Casodex to the androgen receptor. Mukherjee A; Kirkovsky L; Yao XT; Yates RC; Miller DD; Dalton JT Xenobiotica; 1996 Feb; 26(2):117-22. PubMed ID: 8867996 [TBL] [Abstract][Full Text] [Related]
17. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells. Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991 [TBL] [Abstract][Full Text] [Related]
18. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Yin D; He Y; Perera MA; Hong SS; Marhefka C; Stourman N; Kirkovsky L; Miller DD; Dalton JT Mol Pharmacol; 2003 Jan; 63(1):211-23. PubMed ID: 12488554 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain. Söderholm AA; Lehtovuori PT; Nyrönen TH J Med Chem; 2005 Feb; 48(4):917-25. PubMed ID: 15715462 [TBL] [Abstract][Full Text] [Related]
20. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Hodgson MC; Astapova I; Hollenberg AN; Balk SP Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]